Kusumoto H - Search Results

1

Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.

Maehara Y, Inutsuka S, Takeuchi H, Baba H, Kusumoto H, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Cancer Chemother Pharmacol. 1993;33(2):171-5. doi: 10.1007/BF00685337. Cancer Chemother Pharmacol. 1993. PMID: 8261578

2

5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.

Maehara Y, Sakaguchi Y, Takahashi I, Yoshida M, Kusumoto H, Masuda H, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Cancer Chemother Pharmacol. 1992;29(4):257-60. doi: 10.1007/BF00685941. Cancer Chemother Pharmacol. 1992. PMID: 1537070

3

Postoperative chemotherapy for patients with advanced gastric cancer.

Maehara Y, Emi Y, Moriguchi S, Takahashi I, Yoshida M, Kusumoto H, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Am J Surg. 1992 Jun;163(6):577-80. doi: 10.1016/0002-9610(92)90560-e. Am J Surg. 1992. PMID: 1595836

4

Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time.

Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Cancer. 1992 Jul 15;70(2):392-5. doi: 10.1002/1097-0142(19920715)70:2<392::aid-cncr2820700204>3.0.co;2-p. Cancer. 1992. PMID: 1617589

5

UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.

Maehara Y, Kusumoto T, Kusumoto H, Anai H, Sugimachi K. Maehara Y, et al. Among authors: kusumoto t, kusumoto h. Chemotherapy. 1988;34(6):484-9. doi: 10.1159/000238613. Chemotherapy. 1988. PMID: 3149571

6

Postoperative chemotherapy for gastric cancer in the elderly.

Maehara Y, Yamamoto M, Endo K, Baba H, Kusumoto H, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Chemotherapy. 1994 Jul-Aug;40(4):279-86. doi: 10.1159/000239205. Chemotherapy. 1994. PMID: 8082416

7

Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.

Takahashi I, Maehara Y, Kusumoto H, Kohnoe S, Sugimachi K. Takahashi I, et al. Among authors: kusumoto h. Cancer Chemother Pharmacol. 1993;33(1):31-5. doi: 10.1007/BF00686019. Cancer Chemother Pharmacol. 1993. PMID: 8269586

8

Predictive value of preoperative serum sialyl Tn antigen levels in prognosis of patients with gastric cancer.

Takahashi I, Maehara Y, Kusumoto T, Yoshida M, Kakeji Y, Kusumoto H, Furusawa M, Sugimachi K. Takahashi I, et al. Among authors: kusumoto t, kusumoto h. Cancer. 1993 Sep 15;72(6):1836-40. doi: 10.1002/1097-0142(19930915)72:6<1836::aid-cncr2820720607>3.0.co;2-7. Cancer. 1993. PMID: 8364861

9

Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65.

Maehara Y, Takahashi I, Yoshida M, Baba H, Kusumoto H, Anai H, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Anticancer Res. 1993 Jan-Feb;13(1):27-9. Anticancer Res. 1993. PMID: 8476223 Clinical Trial.

10

Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma.

Maehara Y, Kakeji Y, Watanabe A, Baba H, Kusumoto H, Kohnoe S, Sugimachi K. Maehara Y, et al. Among authors: kusumoto h. Cancer. 1999 Jan 15;85(2):302-8. Cancer. 1999. PMID: 10023696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters